Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer.
Nat Rev Urol
; 17(9): 513-525, 2020 09.
Article
in En
| MEDLINE
| ID: mdl-32678343
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
/
BCG Vaccine
/
Adjuvants, Immunologic
/
Immunotherapy
Limits:
Humans
Language:
En
Journal:
Nat Rev Urol
Journal subject:
UROLOGIA
Year:
2020
Document type:
Article
Affiliation country:
Netherlands
Country of publication:
United kingdom